What we all have in common is our passionate desire to advance science to develop the best therapies for patients with profound unmet medical needs

Entrada Therapeutics is a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics

Headquartered in Boston, Mass., Entrada is a private company that closed on its Series A in December 2018. To date, Entrada has raised over $50 million from 5AM Ventures, MPM Capital, Roche Venture Fund, MRL Ventures Fund and Agent Capital.

At Entrada, we’re tackling a wide range of diseases and targets. Our team is comprised of dedicated experts and leaders focused on advancing our technology platforms to yield treatments for patients in need.

Our Values

  • Humanity

    We genuinely care about patients and about one another

  • Tenacity

    We’re relentless and persistent in the pursuit of developing therapies for patients

  • Creativity

    We’re creative problem solvers

  • Collaboration

    We’re more than the sum of our parts

  • Curiosity

    We’ve got a growth mindset

Join our team if you share our values, our devotion to science and our passion for helping patients.

Current Openings

December 01, 2019
October 25, 2019
October 25, 2019
October 25, 2019
October 25, 2019